SNG Pharmaceuticals Private Limited
About SNG Pharmaceuticals Private Limited
Data last updated:
SNG Pharmaceuticals Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the medicinal chemical and botanical products segment of the chemicals sector. It was incorporated on 25 April 2003 and has been in existence for over 23 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24230MH2003PTC140164.
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Amit Gupta and Anil Surendranath Gupta.
Its last annual general meeting (AGM) was held on 22 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 34/133 Laxmi Industrial Estatenew Link Road Andheri (West), Mumbai, Maharashtra, India – 400053.
As per the financials filed for FY 2025, the company reported a revenue of ₹96.57 Lakh, a growth of 10% compared to the previous year. For the same year it recorded a net profit of ₹72.11 Lakh (net margin 74.7%) and EBITDA of ₹90.24 Lakh (EBITDA margin 93.4%). Revenue has grown at a compounded annual rate (CAGR) of 26% over three years and 9% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered Address34/133 Laxmi Industrial Estatenew Link Road Andheri (West), Mumbai, Maharashtra, India – 400053
- IndustryChemicals, Medicinal Chemical & Botanical Products, Pharmaceuticals, Chemical Products
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Financials of SNG Pharmaceuticals Private Limited
FY 2025 filings availableSNG Pharmaceuticals Private Limited reported revenue of ₹96.57 Lakh (up 10% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 9% over five years, including 10% growth in the latest year. EBITDA rose 12% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2020-21 to FY 2023-24in the company report |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | •••• | |
| Other Income | •••• | |
| Total Revenue | •••• | |
| Cost of Materials Consumed | •••• | |
| Employee Benefit Expense | •••• | |
| Finance Costs | •••• | |
| Depreciation and Amortisation | •••• | |
| Other Expenses | •••• | |
| Total Expenses | •••• | |
| EBITDA | ₹90.24 Lakh | |
| Profit Before Tax | •••• | |
| Tax Expense | •••• | |
| Net Profit (PAT) | ₹72.11 Lakh | |
| Balance Sheet | ||
| Share Capital | •••• | |
| Reserves and Surplus | •••• | |
| Net Worth (Total Equity) | •••• | |
| Long-term Borrowings | •••• | |
| Short-term Borrowings | •••• | |
| Trade Payables | •••• | |
| Total Liabilities | •••• | |
| Fixed Assets | •••• | |
| Investments | •••• | |
| Inventories | •••• | |
| Trade Receivables | •••• | |
| Cash and Bank Balance | •••• | |
| Total Assets | •••• | |
Financial Ratios
| Metrics | FY 2024-25 | FY 2020-21 to FY 2023-24in the company report |
|---|---|---|
| Profitability | ||
| EBITDA Margin | 93.4% | |
| Net Profit Margin | 74.7% | |
| Return on Equity (ROE) | •••• | |
| Return on Capital Employed (ROCE) | •••• | |
| Return on Assets (ROA) | •••• | |
| Liquidity and Debt | ||
| Current Ratio | •••• | |
| Quick Ratio | •••• | |
| Debt-to-Equity Ratio | •••• | |
| Interest Coverage Ratio | •••• | |
| Efficiency and Growth | ||
| Asset Turnover | •••• | |
| Receivable Days | •••• | |
| Payable Days | •••• | |
| Inventory Days | •••• | |
| Revenue Growth | •••• | |
| Net Profit Growth | •••• | |
Paid data: the figures shown as dots, and every line for FY 2020-21 to FY 2023-24, are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of SNG Pharmaceuticals are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Board of Directors of SNG Pharmaceuticals Private Limited
SNG Pharmaceuticals has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Amit Gupta Also directs: Adit Pharma Private Limited, Zen Pharma Private Limited, Gujarat Ampoules and Vials Pvt Ltd and 3 more | Director | 25 Apr 2003 | 23 Years 5 Months | Current |
| Renu Anil Gupta Also directs: Adit Pharma Private Limited, Gujarat Ampoules and Vials Pvt Ltd, Adit Containers Private Limited and 2 more | Additional Director | 13 Jun 2025 | 1 Years 4 Months | Current |
| Anil Surendranath Gupta Also directs: Adit Pharma Private Limited, Zen Pharma Private Limited, Gujarat Ampoules and Vials Pvt Ltd and 3 more | Director | 25 Apr 2003 | 23 Years 5 Months | Current |
Peer Comparison
SNG Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Hermadis Pharmaceuticals Private Limited | ₹97.59 Lakh (FY 2023) | •••• | •••• | -79.0% | •••• | Chennai, Tamil Nadu, India |
| Biocordis Pharmaceuticals Private Limited | ₹97.53 Lakh (FY 2025) | •••• | •••• | 3.0% | •••• | Chandigarh, India |
| Brainstem Pharmaceuticals (OPC) Private Limited | ₹97.06 Lakh (FY 2025) | •••• | •••• | 44.0% | •••• | Medchal, Telangana, India |
| Nuthelia Pharmaceuticals Private Limited | ₹96.95 Lakh (FY 2025) | •••• | •••• | 16.0% | •••• | Delhi, India |
| Doqtec Pharmaceuticals Private Limited | ₹96.83 Lakh (FY 2025) | •••• | •••• | 37.0% | •••• | Bhiwani, Haryana, India |
| SNG Pharmaceuticals Private Limited this company | ₹96.57 Lakh (FY 2025) | •••• | •••• | 10.0% | •••• | Mumbai, Maharashtra, India |
| RML Pharmaceuticals Private Limited | ₹96.47 Lakh (FY 2016) | •••• | •••• | 1186.0% | •••• | New Delhi, Delhi, India |
| Medrica Pharmaceuticals Private Limited | ₹96.26 Lakh (FY 2025) | •••• | •••• | -6.0% | •••• | Hyderabad, Telangana, India |
| Keven Pharmaceuticals Private Limited | ₹96.21 Lakh (FY 2023) | •••• | •••• | 465.0% | •••• | Balapur, Telangana, India |
| Zealous Pharmaceuticals Private Limited | ₹95.71 Lakh (FY 2025) | •••• | •••• | 9.0% | •••• | Bhopal, Madhya Pradesh, India |
| Dr. Bird Pharmaceuticals (OPC) Private Limited | ₹95.56 Lakh (FY 2024) | •••• | •••• | 146.0% | •••• | Mumbai, Maharashtra, India |
Peers are the companies nearest to SNG Pharmaceuticals by revenue, above and below it, in the Pharma industry (Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details
SNG Pharmaceuticals Private Limited is audited by S. V. DOSHI & CO. for the financial year 2017.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| S. V. DOSHI & CO. | Locked | Locked | Locked |
: available in the company report
Ownership and Shareholding
: available in the company report
Charges & Borrowings
SNG Pharmaceuticals Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance
Employment history and EPFO contributions of people linked to SNG Pharmaceuticals.
: available in the company report
Recent Activity
SNG Pharmaceuticals Private Limited has 3 board changes on record since 2003: 3 appointments. The latest: Renu Anil Gupta was appointed as Additional Director on 13 Jun 2025.
Credit Ratings, Litigation & Regulatory Alerts
: available in the company report
MSME Payment Delays
: available in the company report
Subsidiaries & Group Companies
: available in the company report
GST Compliance
: available in the company report
MCA Filings & Documents
: available in the company report
Frequently Asked Questions
SNG Pharmaceuticals is an active private limited company based in Mumbai, Maharashtra, India. The company works in medicinal chemical and botanical products, within the chemicals industry. It was incorporated on 25 April 2003 (23+ years old) and is registered under CIN U24230MH2003PTC140164.
SNG Pharmaceuticals has 3 current directors:
- Amit Gupta - Director
- Renu Anil Gupta - Additional Director
- Anil Surendranath Gupta - Director
The latest financial statements of SNG Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 22 September 2025. Year-wise statements from 2015 are in the company report.
The CIN (Corporate Identification Number) of SNG Pharmaceuticals is U24230MH2003PTC140164. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
SNG Pharmaceuticals was incorporated on 25 April 2003, making it 23+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of SNG Pharmaceuticals by revenue are Hermadis Pharmaceuticals Private Limited, Biocordis Pharmaceuticals Private Limited, Brainstem Pharmaceuticals (OPC) Private Limited, Nuthelia Pharmaceuticals Private Limited, Doqtec Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Pharmaceuticals).
Renu Anil Gupta was appointed as Additional Director on 13 Jun 2025. Amit Gupta was appointed as Director on 25 Apr 2003. Anil Surendranath Gupta was appointed as Director on 25 Apr 2003.
The registered office of SNG Pharmaceuticals is at 34133 Laxmi Industrial Estatenew Link Road Andheri West, Mumbai, Maharashtra, India – 400053.
SNG Pharmaceuticals operates in the chemicals industry, in the medicinal chemical and botanical products segment.
The compliance status of SNG Pharmaceuticals is compliant as of 13 August 2026. The company is actively filing with the Registrar of Companies.
SNG Pharmaceuticals can be reached at its registered office: 34133 Laxmi Industrial Estatenew Link Road Andheri West, Mumbai, Maharashtra, India – 400053.